Rosuvastatin Calcium

4 trials 2 recruiting CCardiology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

6 Sponsors

5 Countries

Phase III

Phase IV

Phase I (Other)

Other

Phase III: 1 Phase IV: 1 Phase I (Other): 1 Other: 1

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Deep vein thrombosis 1 Pulmonary embolism 1 Post procedural pulmonary embolism 1 Hypertension 1 Venous thrombosis 1 Deep vein thrombosis postoperative 1 Pulmonary venous thrombosis 1

Sponsors using this IMP

Adamed Pharma S.A. 1 Centre Hospitalier Regional Et Universitaire De Brest 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Ostfold Hospital Trust 1 Ottawa Hospital Research Institute 1 Pfizer Inc. 1

All trials

4 total

Optimizing therapy with n=1-studies: negating the 'nocebo' effect in statin-intolerance Recruiting

2023-507489-20-00 Phase IV 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
StAtins for Venous Event Reduction in Patients with Venous Thromboembolism : The SAVER Trial Recruiting

2023-504486-23-00 Phase III 2 countries Centre Hospitalier Regional Et Universitaire De Brest; Ostfold Hospital Trust; O…
Randomized, open-label, single dose, two-period, cross-over bioequivalence study comparing test formulation Rosuvastatin/Amlodipine/Ramipril… Ended

2023-503822-38-00 1 country Adamed Pharma S.A.
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended

2023-503570-20-00 Phase I (Other) 1 country Pfizer Inc.

Showing 1–4 of 4 trials

← All drugs A–Z